| abstract |
PROBLEM TO BE SOLVED: To inhibit tyrosine phosphatase activity such as CD45, PTP1C, PTP1B and PTP-TC, diabetes, immune dysfunction, proliferative disorder, brain disease, various allergies, autoimmune diseases, neoplastic diseases, obesity, Alzheimer's disease, To provide a novel tyrosine phosphatase inhibitor useful for the treatment of Parkinson's disease and the like, as well as the regulation of T cell proliferation and the prevention of carcinogenesis. An inhibitor of tyrosine phosphatase containing CD45, PTP1C, PTP1B, and PTP-TC, comprising a dry powder of Chlorella pyrenoidosa with a disrupted cell wall. [Selection figure] None |